Back
Roivant Sciences Vs. Akari Therapeutics PLC Industry Stock Comparison
Sell
25
ROIV
Roivant Sciences
Last Price:
$11.69
Seasonality Move:
-17.6%
Buy
51
AKTX
Akari Therapeutics PLC
Last Price:
$1.29
Seasonality Move:
-7.58%
Sell
25
Roivant Sciences (ROIV)
is a Sell
Is Roivant Sciences a Buy, Sell or Hold?
-
The current Roivant Sciences [ROIV] share price is $11.69. The Score for ROIV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
ROIV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Akari Therapeutics PLC (AKTX)
is a Buy
Is Akari Therapeutics PLC a Buy, Sell or Hold?
-
The current Akari Therapeutics PLC [AKTX] share price is $1.31. The Score for AKTX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
AKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ROIV Stock Price Chart
What is Roivant Sciences's stock price today?
-
The Roivant Sciences share price today is $11.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ROIV is experiencing selling pressure, which indicates risk of future bearish movement.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $1.31The current trend is relatively stagnant and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ROIV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 46.25 | Sell |
Chaikin Money Flow: | -2947840 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.7 - 12.34) | Sell |
Bollinger Bands (100): | (11.47 - 12.17) | Sell |
AKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 54.46 | Buy |
Chaikin Money Flow: | 40884 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.96 - 1.24) | Buy |
Bollinger Bands (100): | (1.44 - 3.34) | Sell |
ROIV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.85 | Sell |
20-day SMA: | 11.92 | Sell |
50-day SMA: | 11.89 | Sell |
200-day SMA: | 11.35 | Buy |
8-day EMA: | 11.82 | Sell |
20-day EMA: | 11.89 | Sell |
50-day EMA: | 11.87 | Sell |
200-day EMA: | 11.38 | Buy |
AKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.08 | Buy |
20-day SMA: | 1.06 | Buy |
50-day SMA: | 1.6 | Sell |
200-day SMA: | 2.38 | Sell |
8-day EMA: | 1.13 | Buy |
20-day EMA: | 1.15 | Buy |
50-day EMA: | 1.55 | Sell |
200-day EMA: | 2.48 | Sell |
Roivant Sciences Earnings Growth & ROIV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and a decrease next year of $0.23 per share.
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Roivant Sciences Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akari Therapeutics PLC Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |